Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

KENNETH R MASSEY

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1073627691
CMS profile
10703035
Location
TERRE HAUTE, IN

General Payments · PY2021–2025

$2,192.91

  • Reported across 138 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$346.75

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $346.75 14

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $174.50 4
Corcept Therapeutics $73.73 4
Amgen Inc. $32.04 2
Lilly USA, LLC $18.23 1
Novo Nordisk AS $17.75 1
PFIZER INC. $15.79 1
Exact Sciences Corporation $14.71 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $324.84 22
PY2022 $342.14 23
PY2023 $731.80 59
PY2024 $447.38 20
PY2025 $346.75 14

Payment records · PY2025 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $14.84 03/12/2025 Food and Beverage Undisputed 06/30/2026 1228782478 CMS
Amgen Inc. $17.20 11/20/2025 Food and Beverage Undisputed 06/30/2026 1228782475 CMS
AstraZeneca Pharmaceuticals LP $121.30 01/03/2025 Food and Beverage Undisputed 06/30/2026 1206253593 CMS
AstraZeneca Pharmaceuticals LP $15.43 05/21/2025 Food and Beverage Undisputed 06/30/2026 1206473203 CMS
AstraZeneca Pharmaceuticals LP $15.88 07/02/2025 Food and Beverage Undisputed 06/30/2026 1206751579 CMS
AstraZeneca Pharmaceuticals LP $21.89 09/12/2025 Food and Beverage Undisputed 06/30/2026 1207273459 CMS
Corcept Therapeutics $15.30 08/26/2025 Food and Beverage Undisputed 06/30/2026 1214180713 CMS
Corcept Therapeutics $18.78 10/07/2025 Food and Beverage Undisputed 06/30/2026 1214180729 CMS
Corcept Therapeutics $24.53 11/04/2025 Food and Beverage Undisputed 06/30/2026 1214180741 CMS
Corcept Therapeutics $15.12 12/08/2025 Food and Beverage Undisputed 06/30/2026 1214180771 CMS
Exact Sciences Corporation $14.71 05/20/2025 Food and Beverage Undisputed 06/30/2026 1235247414 CMS
Lilly USA, LLC $18.23 04/28/2025 Food and Beverage Undisputed 06/30/2026 1187167677 CMS
Novo Nordisk Inc $17.75 03/10/2025 Food and Beverage Undisputed 06/30/2026 1188528119 CMS
PFIZER INC. $15.79 05/06/2025 Food and Beverage Undisputed 06/30/2026 1229839748 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.